← Evidence map

ReviewJournal of bone and mineral metabolism2023

Differences between zoledronic acid and denosumab for breast cancer treatment.

Takashi IshikawaPubMed ↗Publisher ↗

No numbers read from the abstract.

10 papers cite it

2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 36879056